The chemical class denoted as FMO6 Inhibitors represents a collection of compounds meticulously designed to selectively target FMO6, an isoform of the flavin-containing monooxygenase (FMO) enzyme family. Flavin-containing monooxygenases play a crucial role in xenobiotic metabolism, particularly in the oxidative detoxification of various endogenous and exogenous compounds. FMO6, as a specific isoform within this family, is the subject of active research in biochemistry and pharmacology to elucidate its unique substrate preferences and regulatory mechanisms. Inhibitors within the FMO6 Inhibitors class are intricately engineered molecules with the primary goal of modulating the activity or function of FMO6, thereby inducing an inhibitory effect. Researchers in this field utilize a multifaceted approach, integrating insights from structural biology, medicinal chemistry, and computational modeling to unravel the complex molecular interactions between the inhibitors and the target FMO6.
Structurally, FMO6 Inhibitors are characterized by specific molecular features designed to facilitate selective binding to FMO6. This selectivity is crucial to minimize unintended effects on other FMO isoforms or cellular components, ensuring a focused impact on the intended molecular target. The development of inhibitors within this chemical class involves a comprehensive exploration of structure-activity relationships, optimization of pharmacokinetic properties, and a deep understanding of the molecular mechanisms associated with FMO6. As researchers delve deeper into the functional aspects of FMO6 Inhibitors, the knowledge generated contributes not only to deciphering the specific roles of flavin-containing monooxygenase 6 but also to advancing our broader comprehension of drug metabolism, xenobiotic detoxification, and the intricate regulatory networks involved in cellular processes. The exploration of FMO6 Inhibitors stands as a significant avenue for expanding fundamental knowledge in biochemistry and pharmacology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methimazole | 60-56-0 | sc-205747 sc-205747A | 10 g 25 g | $70.00 $112.00 | 4 | |
It may act as a competitive inhibitor by binding to the enzyme's active site, thus preventing the enzyme from metabolizing substrates. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
It could bind non-competitively and alter the enzyme's conformation, reducing its activity. | ||||||
Imidazole | 288-32-4 | sc-204776 sc-204776A sc-204776B sc-204776C | 25 g 100 g 1 kg 5 kg | $27.00 $56.00 $84.00 $343.00 | 2 | |
As a structural analog to part of the FMO's active site, imidazole might inhibit the enzyme by competing with substrates. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
By binding to the enzyme, quinidine could affect the enzyme's ability to metabolize its usual substrates. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
It may inhibit the enzyme by interacting with the heme group in the active site of the enzyme. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
It may act as an inhibitor by binding to the active site and preventing substrate access. | ||||||
Indole-3-carbinol | 700-06-1 | sc-202662 sc-202662A sc-202662B sc-202662C sc-202662D | 1 g 5 g 100 g 250 g 1 kg | $39.00 $61.00 $146.00 $312.00 $1032.00 | 5 | |
As a competitive inhibitor, it might interfere with substrate binding, reducing enzyme activity. | ||||||